You could feel Herman Cain’s presence last week on the biotech beat. And there was a lot of grousing about it.
Cain, the Republican presidential candidate known for his simple 9-9-9 tax plan and some dubious extra-curricular activities, didn’t attend the Personalized Medicine Conference at Harvard Medical School. But a former advisor to President Obama, Ezekiel Emanuel, was there channeling his inner Cain, delivering a simple, blunt message to top biomedical researchers, business executives, and investors.
The word from Emanuel, the University of Pennsylvania bioethicist and player in the landmark healthcare reform law of 2010, boiled down to this: Personalized medicine is a lot of hype, it will add costs to the healthcare system, and we can’t afford it. What personalized medicine ought to offer, he said, is a “1-100-0″ plan. That means treatments that are truly tailored for a single individual; almost 100 percent effective; and have almost zero side effects.
To read the full, original article click on this link: The Herman Cain-Inspired “1-100-0″ Plan for Personalized Medicine? | Xconomy
